STI Pharmaceuticals Company HistoryMarch 2006 STI Pharmaceuticals granted Home office approval STI Pharmaceuticals granted Home Office approval to supply UK clinicians with bespoke cannabinoid preparations. This allows STI Pharmaceuticals to develop and supply a range of Schedule I and Schedule II controlled drugs for UK-based clinical research.
|
|